Clinical trials: Joint Infection

Psoriasis

Post-Marketing Surveillance Study of OTEZLA

• Completed
• Age: All ages
• Observational study

To evaluate the safety and efficacy of OTEZLA in actual clinical settings of use in patients with Psoriasis vulgaris that is with an inadequate response to topical therapies and Psoriasis arthropathica 1.

Trial name

NCT03284879

Where

Japan

Volunteers

1,086 people

Sponsor

Amgen